PMC:3312845 / 926-1530 JSONTXT 21 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T338 0-9 VB denotes Following
T339 10-12 NN denotes SE
T340 12-13 -COMMA- denotes ,
T341 14-18 RB denotes most
T342 19-28 VB denotes activated
T343 29-38 NN denotes microglia
T344 39-45 VB denotes showed
T345 46-52 JJ denotes strong
T346 53-58 NN denotes TNF-α
T347 59-75 NN denotes immunoreactivity
T348 77-79 IN denotes In
T349 80-88 NN denotes addition
T350 88-89 -COMMA- denotes ,
T351 90-93 NN denotes TNF
T352 94-97 NN denotes p75
T353 98-106 NN denotes receptor
T354 107-117 NN denotes expression
T355 118-121 VB denotes was
T356 122-130 VB denotes detected
T357 131-133 IN denotes in
T358 134-145 JJ denotes endothelial
T359 146-151 NN denotes cells
T360 152-154 RB denotes as
T361 155-159 RB denotes well
T362 160-162 IN denotes as
T363 163-173 NN denotes astrocytes
T364 175-177 IN denotes In
T365 178-186 NN denotes addition
T366 186-187 -COMMA- denotes ,
T367 188-192 RB denotes only
T368 193-203 NN denotes p65-Thr435
T369 204-219 NN denotes phosphorylation
T370 220-223 VB denotes was
T371 224-233 VB denotes increased
T372 234-236 IN denotes in
T373 237-248 JJ denotes endothelial
T374 249-254 NN denotes cells
T375 255-266 VB denotes accompanied
T376 267-269 IN denotes by
T377 270-276 NN denotes SMI-71
T378 277-287 NN denotes expression
T379 288-289 -LRB- denotes (
T380 289-291 DT denotes an
T381 292-303 JJ denotes endothelial
T382 304-311 NN denotes barrier
T383 312-319 NN denotes antigen
T384 319-320 -RRB- denotes )
T385 322-336 NN denotes Neutralization
T386 337-339 IN denotes of
T387 340-345 NN denotes TNF-α
T388 346-348 IN denotes by
T389 349-356 JJ denotes soluble
T390 357-360 NN denotes TNF
T391 361-364 NN denotes p55
T392 365-373 NN denotes receptor
T393 374-375 -LRB- denotes (
T394 375-383 NN denotes sTNFp55R
T395 383-384 -RRB- denotes )
T396 385-393 NN denotes infusion
T397 394-404 VB denotes attenuated
T398 405-415 JJ denotes SE-induced
T399 416-425 JJ denotes vasogenic
T400 426-431 NN denotes edema
T401 432-435 CC denotes and
T402 436-444 JJ denotes neuronal
T403 445-452 NN denotes damages
T404 453-456 IN denotes via
T405 457-467 NN denotes inhibition
T406 468-470 IN denotes of
T407 471-481 NN denotes p65-Thr435
T408 482-497 NN denotes phosphorylation
T409 498-500 IN denotes in
T410 501-512 JJ denotes endothelial
T411 513-518 NN denotes cells
T412 520-531 RB denotes Furthermore
T413 531-532 -COMMA- denotes ,
T414 533-541 NN denotes sTNFp55R
T415 542-550 NN denotes infusion
T416 551-558 VB denotes reduced
T417 559-569 JJ denotes SE-induced
T418 570-580 NN denotes neutrophil
T419 581-593 NN denotes infiltration
T420 594-596 IN denotes in
T421 597-600 DT denotes the
T422 601-603 NN denotes PC
R169 T339 T338 arg2Of SE,Following
R170 T343 T341 arg1Of microglia,most
R171 T343 T342 arg2Of microglia,activated
R172 T343 T344 arg1Of microglia,showed
R173 T344 T338 arg1Of showed,Following
R174 T344 T340 arg1Of showed,","
R175 T347 T344 arg2Of immunoreactivity,showed
R176 T347 T345 arg1Of immunoreactivity,strong
R177 T347 T346 arg1Of immunoreactivity,TNF-α
R178 T349 T348 arg2Of addition,In
R179 T354 T351 arg1Of expression,TNF
R180 T354 T352 arg1Of expression,p75
R181 T354 T353 arg1Of expression,receptor
R182 T354 T355 arg1Of expression,was
R183 T354 T356 arg2Of expression,detected
R184 T356 T348 arg1Of detected,In
R185 T356 T350 arg1Of detected,","
R186 T356 T355 arg2Of detected,was
R187 T356 T357 arg1Of detected,in
R188 T359 T358 arg1Of cells,endothelial
R189 T359 T362 arg1Of cells,as
R190 T362 T357 arg2Of as,in
R191 T362 T360 arg1Of as,as
R192 T362 T361 arg1Of as,well
R193 T363 T362 arg2Of astrocytes,as
R194 T365 T364 arg2Of addition,In
R195 T369 T367 arg1Of phosphorylation,only
R196 T369 T368 arg1Of phosphorylation,p65-Thr435
R197 T369 T370 arg1Of phosphorylation,was
R198 T369 T371 arg2Of phosphorylation,increased
R199 T371 T364 arg1Of increased,In
R200 T371 T366 arg1Of increased,","
R201 T371 T370 arg2Of increased,was
R202 T371 T372 arg1Of increased,in
R203 T374 T372 arg2Of cells,in
R204 T374 T373 arg1Of cells,endothelial
R205 T374 T375 arg2Of cells,accompanied
R206 T378 T375 arg1Of expression,accompanied
R207 T378 T376 arg2Of expression,by
R208 T378 T377 arg1Of expression,SMI-71
R209 T378 T379 arg1Of expression,(
R210 T383 T379 arg2Of antigen,(
R211 T383 T380 arg1Of antigen,an
R212 T383 T381 arg1Of antigen,endothelial
R213 T383 T382 arg1Of antigen,barrier
R214 T384 T379 arg3Of ),(
R215 T385 T386 arg1Of Neutralization,of
R216 T385 T388 arg1Of Neutralization,by
R217 T385 T397 arg1Of Neutralization,attenuated
R218 T387 T386 arg2Of TNF-α,of
R219 T392 T389 arg1Of receptor,soluble
R220 T392 T390 arg1Of receptor,TNF
R221 T392 T391 arg1Of receptor,p55
R222 T392 T393 arg1Of receptor,(
R223 T394 T393 arg2Of sTNFp55R,(
R224 T395 T393 arg3Of ),(
R225 T396 T388 arg2Of infusion,by
R226 T396 T392 arg1Of infusion,receptor
R227 T397 T404 arg1Of attenuated,via
R228 T399 T400 arg1Of vasogenic,edema
R229 T399 T401 arg1Of vasogenic,and
R230 T402 T401 arg2Of neuronal,and
R231 T403 T397 arg2Of damages,attenuated
R232 T403 T398 arg1Of damages,SE-induced
R233 T403 T399 arg1Of damages,vasogenic
R234 T403 T402 arg1Of damages,neuronal
R235 T405 T404 arg2Of inhibition,via
R236 T405 T406 arg1Of inhibition,of
R237 T408 T406 arg2Of phosphorylation,of
R238 T408 T407 arg1Of phosphorylation,p65-Thr435
R239 T408 T409 arg1Of phosphorylation,in
R240 T411 T409 arg2Of cells,in
R241 T411 T410 arg1Of cells,endothelial
R242 T415 T414 arg1Of infusion,sTNFp55R
R243 T415 T416 arg1Of infusion,reduced
R244 T416 T412 arg1Of reduced,Furthermore
R245 T416 T413 arg1Of reduced,","
R246 T419 T416 arg2Of infiltration,reduced
R247 T419 T417 arg1Of infiltration,SE-induced
R248 T419 T418 arg1Of infiltration,neutrophil
R249 T419 T420 arg1Of infiltration,in
R250 T422 T420 arg2Of PC,in
R251 T422 T421 arg1Of PC,the